Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluating Predictors of Immune-Related Adverse Events and Response to Checkpoint Inhibitors in Myeloid Malignancies.
Gesiotto QJ, Swoboda DM, Shallis RM, Al Ali N, Padron E, Kuykendall AT, Song J, Talati C, Sweet K, Lancet JE, Zeidan AM, Komrokji RS, Sallman DA. Gesiotto QJ, et al. Among authors: sweet k. Clin Lymphoma Myeloma Leuk. 2021 Jun;21(6):421-424.e2. doi: 10.1016/j.clml.2021.01.010. Epub 2021 Jan 20. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33583730 No abstract available.
Novel therapeutics in acute myeloid leukemia.
Sweet K, Lancet JE. Sweet K, et al. Curr Hematol Malig Rep. 2014 Jun;9(2):109-17. doi: 10.1007/s11899-014-0199-0. Curr Hematol Malig Rep. 2014. PMID: 24633743 Review.
Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: Analysis from a large, single institution experience.
Griffin PT, Komrokji RS, Sweet K, Al Ali NH, Padron E, Kubal TE, List AF, Lancet JE. Griffin PT, et al. Among authors: sweet k. Am J Hematol. 2017 Mar;92(3):232-237. doi: 10.1002/ajh.24627. Epub 2017 Feb 3. Am J Hematol. 2017. PMID: 28006850 Free article.
The Treatment Landscape of Myelofibrosis Before and After Ruxolitinib Approval.
Kuykendall AT, Talati C, Al Ali N, Sweet K, Padron E, Sallman DA, Lancet JE, List AF, Zuckerman KS, Komrokji RS. Kuykendall AT, et al. Among authors: sweet k. Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):e45-e53. doi: 10.1016/j.clml.2017.08.002. Epub 2017 Aug 5. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28869184
280 results